| Patent | Date |
|---|
Composition For Promoting Hair Growth Comprising A Guanine Derivative
App 20220000811 - SON; Myung Jin ; et al. | 2022-01-06 |
Biguanide Compound And Use Thereof
App 20200277255 - KIM; Hong Woo ; et al. | 2020-09-03 |
Biguanide compound and use thereof
Grant 10,626,085 - Kim , et al. | 2020-04-21 |
Antibody Binding To Fcrn For Treating Autoimmune Diseases
App 20200109201 - KIM; Sung Wuk ; et al. | 2020-04-09 |
Guanidine compounds and use thereof
Grant 10,590,081 - Kim , et al. | 2020-03-17 |
Antibody binding to FcRn for treating autoimmune diseases
Grant 10,544,226 - Kim , et al. Ja | 2020-01-28 |
Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
Grant 10,376,480 - Kim , et al. A | 2019-08-13 |
Antibody binding to FcRn for treating autoimmune diseases
Grant 10,336,825 - Kim , et al. | 2019-07-02 |
Antibody Binding To Fcrn For Treating Autoimmune Diseases
App 20190135917 - KIM; Sung Wuk ; et al. | 2019-05-09 |
FcRn-specific human antibody and composition for treatment of autoimmune diseases
Grant 10,280,207 - Kim , et al. | 2019-05-07 |
Biguanide Derivative, A Preparation Method Thereof, And A Pharmaceutical Composition Containing The Biguanide Derivative As An Active Ingredient
App 20180256520 - KIM; Sung Wuk ; et al. | 2018-09-13 |
Pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis
Grant 10,058,558 - Kim , et al. August 28, 2 | 2018-08-28 |
Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient
Grant 9,993,446 - Kim , et al. June 12, 2 | 2018-06-12 |
Guanidine Compounds And Use Thereof
App 20180093953 - KIM; Sung Wuk ; et al. | 2018-04-05 |
Biguanide Compound And Use Thereof
App 20180044283 - KIM; Hong Woo ; et al. | 2018-02-15 |
Heteroaryl Compounds Comprising Nitrogen And Use Thereof
App 20170305861 - Kim; Sung Wuk ; et al. | 2017-10-26 |
Antibody Binding To Fcrn For Treating Autoimmune Diseases
App 20170210801 - Kim; Sung Wuk ; et al. | 2017-07-27 |
Antibody Binding To Fcrn For Treating Autoimmune Diseases
App 20170210805 - Kim; Sung Wuk ; et al. | 2017-07-27 |
Guanidine Compounds And Use Thereof
App 20170073331 - Kim; Sung Wuk ; et al. | 2017-03-16 |
Uses of modified human tumor necrosis factor receptor-1 polypeptide
Grant 9,580,490 - Kim , et al. February 28, 2 | 2017-02-28 |
Pharmaceutical composition comprising a biguanide derivative as an active ingredient for preventing or treating glioblastoma
Grant 9,539,238 - Kang , et al. January 10, 2 | 2017-01-10 |
N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
Grant 9,540,325 - Kim , et al. January 10, 2 | 2017-01-10 |
Pharmaceutical Composition Comprising A Biguanide Derivative As An Active Ingredient For Preventing Or Treating Glioblastoma
App 20160331724 - Kang; Seok Gu ; et al. | 2016-11-17 |
Biguanide Derivative, A Preparation Method Thereof, And A Pharmaceutical Composition Containing The Biguanide Derivative As An Active Ingredient
App 20160317478 - Kim; Sung Wuk ; et al. | 2016-11-03 |
Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
Grant 9,464,042 - Kim , et al. October 11, 2 | 2016-10-11 |
Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
Grant 9,416,098 - Kim , et al. August 16, 2 | 2016-08-16 |
Fcrn-specific Human Antibody And Composition For Treatment Of Autoimmune Diseases
App 20160137713 - Kim; Sung Wuk ; et al. | 2016-05-19 |
N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
Grant 9,321,742 - Kim , et al. April 26, 2 | 2016-04-26 |
Pharmaceutical Composition Comprising N1-cyclic Amine-n5-substituted Biguanide Derivatives As An Ingredient For Preventing Or Treating Fibrosis
App 20160101112 - Kim; Sung Wuk ; et al. | 2016-04-14 |
Biguanide Derivative, Preparation Method Thereof, And Pharmaceutical Composition Containing Same As An Active Ingredient
App 20150376123 - Kim; Sung Wuk ; et al. | 2015-12-31 |
Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
Grant 9,133,110 - Kim , et al. September 15, 2 | 2015-09-15 |
Uses Of Modified Human Tumor Necrosis Factor Receptor-1 Polypeptide
App 20150119338 - Kim; Sung Wuk ; et al. | 2015-04-30 |
Bosentan Controlled Release Oral Preparation
App 20140377346 - Kim; Sung Wuk ; et al. | 2014-12-25 |
Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
Grant 8,895,500 - Kim , et al. November 25, 2 | 2014-11-25 |
Pharmaceutical Composition Having Activity Of Anticancer
App 20140235558 - Kim; Sung-Wuk ; et al. | 2014-08-21 |
Anti-cancer Pharmaceutical Composition
App 20140235559 - Kim; Sung-Wuk ; et al. | 2014-08-21 |
N1-Cyclic Amine-N5-Substituted Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same
App 20140179661 - Kim; Sung Wuk ; et al. | 2014-06-26 |
N1-Cyclic Amine-N5-Substituted Phenyl Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same
App 20140179660 - Kim; Sung Wuk ; et al. | 2014-06-26 |
Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
Grant 8,754,037 - Kim , et al. June 17, 2 | 2014-06-17 |
1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
Grant 8,722,674 - Cheon , et al. May 13, 2 | 2014-05-13 |
N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredients
Grant 8,648,111 - Kim , et al. February 11, 2 | 2014-02-11 |
Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
Grant 8,642,083 - Kim , et al. February 4, 2 | 2014-02-04 |
N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same
Grant 8,642,647 - Kim , et al. February 4, 2 | 2014-02-04 |
Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
Grant 08618045 - | 2013-12-31 |
N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
Grant 8,541,474 - Kim , et al. September 24, 2 | 2013-09-24 |
Modified Human Tumor Necrosis Factor Receptor-i Polypeptide Or Fragment Thereof, And Method For Preparing Same
App 20130237472 - Kim; Sung Wuk ; et al. | 2013-09-12 |
Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity
App 20130158084 - KIM; Sung Wuk ; et al. | 2013-06-20 |
Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
Grant 8,394,845 - Kim , et al. March 12, 2 | 2013-03-12 |
Biguanide Derivative, Preparation Method Thereof, And Pharmaceutical Composition Containing Same As An Active Ingredient
App 20120309799 - Kim; Sung Wuk ; et al. | 2012-12-06 |
Biguanide Derivative, A Preparation Method Thereof And A Pharmaceutical Composition Containing The Biguanide Derivative As An Active Ingredient
App 20120283299 - Kim; Sung Wuk ; et al. | 2012-11-08 |
Modified Human Tumor Necrosis Factor Receptor-1 Polypeptide Or Fragment Thereof, And Method For Preparing Same
App 20120277142 - Kim; Sung Wuk ; et al. | 2012-11-01 |
Modified Human Tumor Necrosis Factor Receptor-1 Polypeptide Or Fragment Thereof, And Method For Preparing Same
App 20120251486 - Kim; Sung Wuk ; et al. | 2012-10-04 |
Butyric Acid Salt Of N,n-dimethyl Imidocarbon Imidic Diamide, Method Of Preparing Same, And Pharmaceutical Compositions And Combinations Containing Same
App 20120135952 - Kim; Sung Wuk ; et al. | 2012-05-31 |
Combination Preparation Comprising Inhibitor Of Hmg-coa Reductase And Aspirin And Method For Manufacturing The Same
App 20120015032 - Kim; Sung Wuk ; et al. | 2012-01-19 |
N, N -dimethyl Imidodicarbonimidic Diamide Acetate, Method For Producing The Same And Pharmaceutical Compositions Comprising The Same
App 20120010287 - KIM; Sung Wuk ; et al. | 2012-01-12 |
N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
Grant 8,076,377 - Kim , et al. December 13, 2 | 2011-12-13 |
Modified Human Thrombopoietin Polypeptide Fragment And Manufacturing Method Thereof
App 20110294733 - Kim; Sung Wuk ; et al. | 2011-12-01 |
N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
Grant 8,058,312 - Kim , et al. November 15, 2 | 2011-11-15 |
1,3,5-Triazine-2,4,6-Triamine Compound or Pharmaceutical Acceptable Salt Thereof, and Pharmaceutical Composition Comprising the Same
App 20110237587 - Cheon; Hyae Gyeong ; et al. | 2011-09-29 |
Combination Preparation Comprising Angiotensin-ii-receptor Blocker And Hmg-coa Reductase Inhibitor
App 20110212175 - Kim; Sung Wuk ; et al. | 2011-09-01 |
Method Of Using Combination Preparation Comprising Angiotensin-ii-receptor Blocker And Hmg-coa Reductase Inhibitor
App 20110213004 - Kim; Sung Wuk ; et al. | 2011-09-01 |
N1-benzo[1,3]dioxol-5-ylmethyl-n2-substituted Biguanide Derivative, Preparation Method Thereof, And Pharmaceutical Composition Containing Same
App 20110207810 - Kim; Sung Wuk ; et al. | 2011-08-25 |
N 1-2-thiophene-2-ylethyl-n2-substituted Biguanide Derivate, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same As Active Ingredients
App 20110196015 - Kim; Sung Wuk ; et al. | 2011-08-11 |
Pharmaceutical Preparation Containing Non-dihydropyridine Calcium Channel Blocker And Angiotensin-2 Receptor Blocker
App 20110123612 - Kim; Sung Wuk ; et al. | 2011-05-26 |
Pharmaceutical Formulation Containing Angiotensin-ii Receptor Blocker
App 20110117194 - Kim; Sung Wuk ; et al. | 2011-05-19 |
Pharmaceutical Formulation
App 20110111022 - Kim; Sung Wuk ; et al. | 2011-05-12 |
Pharmaceutical Preparation
App 20110111021 - Kim; Sung Wuk ; et al. | 2011-05-12 |
Pharmaceutical Preparation For Treating Cardiovascular Disease
App 20110052683 - Kim; Sung Wuk ; et al. | 2011-03-03 |
Composite Preparation
App 20110038931 - Kim; Sung Wuk ; et al. | 2011-02-17 |
Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
App 20100272797 - Kim; Sung Wuk ; et al. | 2010-10-28 |
N,n-dimethyl Imidodicarbonimidic Diamide Dicarboxylate, Method For Producing The Same And Pharmaceutical Compositions Comprising The Same
App 20100249241 - KIM; Sung Wuk ; et al. | 2010-09-30 |
Controlled Release Pharmaceutical Composition Containing Thiazides And Angiotensin-ii-receptor Blockers
App 20100143470 - Kim; Sung Wuk ; et al. | 2010-06-10 |
N, N -dimethyl Imidodicarbonimidic Diamide Acetate, Method For Producing The Same And Pharmaceutical Compositions Comprising The Same
App 20100087544 - Kim; Sung Wuk ; et al. | 2010-04-08 |
Controlled Release Complex Composition Comprising Angiotensin-ii-receptor Blockers And Hmg-coa Reductase Inhibitors
App 20100074951 - Kim; Sung Wuk ; et al. | 2010-03-25 |
Combined Preparation For The Treatment Of Cardiovascular Diseases Based On Chronotherapy Theory
App 20100047341 - Kim; Sung Wuk ; et al. | 2010-02-25 |
Combined Pharmaceutical Formulation With Controlled-release Comprising Dihydropyridine Calcium Channel Blockers And Hmg-coa Reductase Inhibitors
App 20080241240 - Kim; Sung Wuk ; et al. | 2008-10-02 |
| 